Mankind Pharma has received a certificate confirming compliance with SEBI’s Depositories and Participants Regulations for the quarter ended December 31, 2025. The certificate, provided by KFin Technologies Limited, indicates that no requests for dematerialization or rematerialization of shares were received during the specified period. This ensures adherence to regulatory requirements and maintains investor confidence.
Compliance Confirmation
Mankind Pharma has announced the receipt of a certificate concerning compliance with depositories regulations. The certificate, issued by KFin Technologies Limited, the Registrar and Share Transfer Agent, pertains to the quarter ending December 31, 2025.
Details of the Certificate
The certificate confirms that KFin Technologies Limited did not receive any requests for dematerialization or rematerialization of shares of Mankind Pharma during the period from October 1, 2025, to December 31, 2025. This affirms adherence to the regulations set forth by SEBI.
Source: BSE
